NCT04460690View on ClinicalTrials.gov

Rapid, Onsite COVID-19 Detection

NACompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

July 13, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
COVID-19Sars-CoV2
Interventions
DEVICE

Rapid Onsite COVID-19 Detection

saliva assay test for high concentrations of SARS-CoV-2

Trial Locations (1)

53711

University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

AIDS Vaccine Research Lab

UNKNOWN

lead

University of Wisconsin, Madison

OTHER

NCT04460690 - Rapid, Onsite COVID-19 Detection | Biotech Hunter | Biotech Hunter